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Hydrofluoric acid (HF) is the inorganic acid of elemental fluorine and causes tissue 
damage in humans by two mechanisms; free hydrogen ions cause a caustic burn and 
fluoride ions penetrate tissues resulting in chemical burns.  The mode of action this acid 
assumes is to bind to calcium and magnesium when it comes into contact with skin and 
tissues.  Once HF is absorbed through the skin or eyes, it dissociates and can cause 
extensive damage to tissues by the formation of insoluble fluoride salts.  If enough Ca 
and Mg are absorbed, there may be an inadequate supply available for vital body 
functions.  Exposures to hydrofluoric acid must be treated immediately, as sudden death 
has been reported from acid burns to as little as 2.5% of body surface area.  Two 
treatments available today include calcium gluconate and Hexafluorine.  Calcium 
gluconate works by combining with free fluoride ions to form insoluble calcium fluoride, 
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thus preventing the burns that result from the extraction of calcium from tissue and 
bones.  Depending on the surrounding circumstances, calcium gluconate can also be 
administered by injection or intra-arterial infusion.  
Hexafluorine has both absorption and chelating capacities enabling it to trap H+ and F+ 
ions immediately as it contacts HF.  This ability prevents the superficial layers of skin 
from being destroyed and also halts the fluoride ion advancement.   
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Chapter I 
Statement of the Problem 
 
Introduction 
Since its birth in the 1950’s, the semiconductor industry has been continuously growing.   
Today it is approaching sales of $200 billion dollars per year worldwide.  This industry is 
growing faster than all other “mature” industries indicating that microchips have yet a lot 
of growth potential (Van Zant, P., 2000). 
The semiconductor industry supplies us with many luxuries that we have come to take for 
granted including computers, televisions, telecommunications equipment, industrial 
machinery, aircraft, and military equipment (Moris, F., 1996).  In order to provide these 
amenities and stay competitive in the industry, semiconductor companies need to use the 
best available technology.  Many times, this technology requires the use of a variety of 
chemicals.  In fact, microchip fabrication is primarily a series of chemical processes.  Up 
to 20% of all process steps are wafer surface preparation or cleaning, requiring 
semiconductor companies to consume large quantities of chemicals.  If all the costs of 
production are summed, chemicals can be up to 40% of manufacturing costs (Van Zant, 
P., 2000).   
Semiconductor companies must implement stringent engineering and administrative 
controls to help prevent exposure and reduce the risks associated with chemicals.   Risks 
are managed by developing employee knowledge, skill, and awareness through training 
programs and inspections, however employee exposure to hazardous chemicals continues 
to be a problem (Van Zant, P., 2000).  Many of these chemicals have the potential to 
seriously harm human beings causing burns, systemic poisoning, and in some cases 
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leading to death.  Hydrofluoric acid (HF) is a chemical with unique characteristics that 
make it extremely toxic to humans, and immediate treatment following exposure is 
imperative.  This study will analyze the effectiveness, availability, and cost of treatment 
methodologies used for HF exposures. 
 
Purpose 
The purpose of this study is to compare and contrast calcium gluconate and Hexafluorine 
as treatments for hydrofluoric exposure. 
 
Objectives 
1.0 Examine processes in the semiconductor industry that utilize hydrofluoric acid. 
1.1 Analyze the properties and toxicity of hydrofluoric acid. 
2.0 Analyze and evaluate calcium gluconate and Hexafluorine to establish which is the 
preeminent treatment methodology. 
 
Background and Significance 
Hydrofluoric acid has been used in the industrial setting since the late seventeenth 
century when it was discovered that the acid had the ability to dissolve silica (Dowback, 
Rose, and Rohrich, 1994).  The semiconductor industry has implemented HF into various 
processes including silicon dioxide wet etching, reaction chamber cleaning, and oxide 
etching.  Hydrofluoric acid has become the most common burn-producing chemical in 
the semiconductor industry and its use in operational processes presents the industry with 
a unique chemical hazard (Edelman, 1986).  The distinctive characteristics of HF make it 
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highly toxic to humans. Exposures to the skin and eyes have been associated with severe 
symptoms such as eschar formation, liquefaction necrosis, and sloughing, which develop 
as a result of the hydrogen ion, and systemic fluoride poisoning or death due to the 
fluoride ion. (Upfal and Doyle, 1990). 
A variety of treatment options have been utilized however the majority of them have 
proven to be ineffective (Mistry and Wainwright, 1992).  Two treatment methodologies 
available today include calcium gluconate and a product called Hexafluorine. Calcium 
gluconate can be administered to an exposed employee in the form of a topical gel, 
injection, infusion, or eye drop solution and manages hydrofluoric acid burns by 
precipitating the fluoride ion in the form of an insoluble salt (Mistry and Wainwright, 
1992).  Hexafluorine is a first aid treatment that is used in aqueous form as a rinse or 
wash.  This product has the ability to absorb the corrosive hydrogen ions and bind to the 
fluoride ion, which may eliminate the need for further medical treatment (Hall, Blomet, 
Gross, and Nehles, 1999). 
When deciding which of these products to use, a semiconductor company must carefully 
consider their needs and look at the advantages and disadvantages of each. All aspects of 
each treatment methodology should be weighed however ultimately; the most efficacious 
treatment should be used. This paper focuses on the effectiveness and cost of each option 
in order to establish which is the preeminent treatment. 
Limitations of the Study 
This study was highly directed toward the semiconductor industry.  Although 
hydrofluoric acid is utilized by other industries that may have benefited from the 
information contained in this paper, those industries were not researched in this study. 
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Definition of Terms 
Cardiac Arrhythmia     Irregularity of the heartbeat.        
Chemosis   Eye disorder marked by swelling of the conjunctiva around 
the cornea. 
Conjuctival Inflammation  Inflammation of the thin transparent mucus that lines the 
inside of the eyelid and the exposed surface of the anterior 
sclera up to the border of the cornea. 
Eschar     Scab or slough. 
Erythema    Redness of the skin. 
Hypocalcemia   Marked reduction of calcium in the blood. 
Induration    The hardening of tissue.   
Liquefaction Necrosis  Complete and rapid dissolution of cells by enzymes, 
forming circumscribed areas of softened tissue with  semi- 
fluid exudates. 
Sloughing A mass of dead tissue separating from or being only 
partially attached to a living structure.  
Subungual    Beneath the nail of a toe or finger. 
**Terms taken from Melloni’s Illustrated Medical Dictionary 
 
 
 
 
 
 
 4
Chapter II 
Review of Literature 
 
Introduction 
The purpose of this study is to compare and contrast the effectiveness of calcium 
gluconate and Hexafluorine as treatments for hydrofluoric exposure.  The literature 
review will explain the semiconductor processes that utilize hydrofluoric acid, HF 
toxicity, effectiveness of each treatment methodology, and provide comparisons and 
contrasts in order to establish a basis for the goals and objectives of this study. 
 
Use of Hydrofluoric Acid in the Semiconductor Industry 
 
The semiconductor industry has a variety of chemical processes that involve the use of 
hydrofluoric acid (HF). These processes include the silicon dioxide wet etching process, 
the removal of oxides from the silicon surface, and reaction chamber cleaning.  In the 
silicon dioxide wet etching process, the silicon dioxide is thermally grown and then 
etched with HF.  The hydrofluoric acid dissolves the silicon dioxide but does not attack 
the silicon.  The etch rate of the acid is so fast however, that it needs to be mixed with 
water and ammonium fluoride in order to slow the process.  The resulting compound, 
NH4 – HF, is referred to as buffered oxide etch (BOE).  The concentration of the BOE is 
adjusted as needed (VanZant, 1993).  
 
Hydrofluoric acid is also utilized in the removal of oxides from the wafer.  Oxide layers 
are grown in heated chemical baths after first being cleaned in 49% HF.  The layers are 
thin but have proven to be sufficient in preventing the silicon surface from reacting 
during other processes.  When it comes time for the oxide removal process, HF has been 
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the chemical of choice.  It is used in conjunction with water to form a solution of varying 
concentrations.  The ratio of water to HF ranges from 100:1 to 10:7 depending on the 
thickness of the oxide layer (VanZant, 1993). 
 
The reaction chamber is a component of the tube furnace system in which wafers are 
oxidized.  It protects the wafers from being contaminated and functions to even out the 
temperature in the tubes of the system.  The reaction chamber is commonly composed of 
high-purity quartz.  Quartz is used because of its ability to withstand high temperatures 
and also because it is, for the most part, a clean substance.  However, quartz tubes do 
require periodic cleaning.  One method is to use hydrofluoric acid or a solution of water 
and HF.  The acid cleans the tubes by removing a thin layer of the quartz and therefore, 
over time, the tubes are weakened by the HF cleaning process (VanZant, 1993). 
 
Hydrofluoric acid is the most common burn-producing chemical in the semiconductor 
industry, and its use in operational processes presents the industry with a unique chemical 
hazard. The acid’s distinctive characteristics are what make it so highly toxic to humans 
(Edelman, 1986).  Maintenance employees and “chemical handlers” refilling reservoirs 
are most often at risk of being exposed to the higher concentrations of HF. However, all 
employees must be aware of the risks involved regardless of whether the acid is being 
used a 3% solution at an etch station or as a 50% solution in a quartz cleaning operation 
(Edelman, 1986).   
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Properties and Toxicity of Hydrofluoric Acid 
Hydrofluoric acid, sometimes referred to as hydrogen fluoride, hydrofluoride, or 
monohydride, is the inorganic acid of elemental fluorine (Dowback, Rose, & Rohrich, 
1994).  The properties of HF can be found in Table I. 
 
Table I 
Properties of HF 
 
Appearance Indistinguishable from water at low concentrations; Fuming 
liquid at high concentrations 
Odor Pungent Odor at concentrations less than 1 ppm 
Molecular Weight 20.01 daltons 
Boiling Point 20 degrees Celsius 
Vapor Pressure 400 mmHg 
Vapor Density 0.7 
Flammability Nonflammable 
Corrosiveness Highly Corrosive 
 
Hydrofluoric acid is commonly thought of as a strong acid however it is actually a very 
weak acid.  It has a low dissociation constant (3.5x10-4) resulting from the strong 
electronegativity of the fluoride ion. The fluoride ion, thus, does not readily dissociate 
from the hydrogen ion. This low ionicity makes HF lipophilic and highly permeable 
across membranes (Beiran, Miller, & Bentur, 1997).  In this way, HF acts more like a 
base than an acid. This characteristic is why hydrofluoric acid causes significantly less 
surface damage following exposure than do hydrochloric and sulfuric acids (Mistry & 
Wainwright, 1992).  However, even minor topical injury caused by the hydrogen ion 
alters the protective barrier enough to assist in the penetration of the fluoride ions into 
 7
body tissues (Vance et. al., 1986).  Once the fluoride ion is free, it seeks out calcium and 
magnesium and forms insoluble fluoride salts.  This action lowers the calcium and 
magnesium content of cell membranes thus increasing permeability to potassium (Beiran 
et. al., 1997).  The ionic shift due to potassium is responsible for the extreme pain 
associated with HF exposure (Mistry & Wainwright, 1992).  As calcium is immobilized, 
the result is the formation of tissue abnormalities, cellular metabolism impairment, cell 
injury, and cell death with subsequent tissue necrosis (Vance et. al., 1986).  If the fluoride 
ion is not fully bound in the superficial tissues it will progress and decalcify bone causing 
hypocalcemia, cardiac arrhythmia, and potentially death (Mistry & Wainwright, 1992). 
 
Symptoms  
Exposure to hydrofluoric acid can occur via inhalation, ingestion, or dermal contact.  
Most poisonings occur after HF comes into contact with the skin or eyes and is absorbed 
into the body (www.mednets.com).  The extent of injury is dependent upon variables 
such as the concentration of the acid, the amount of HF involved, the condition of the 
skin or eyes, and the surface area involved (Upfal & Doyle, 1990).  Hydrofluoric acid 
assumes the same mode of action for the eyes and skin however the resulting damage is 
unique to each organ and warrants discussion. 
 
Cutaneous Exposure 
Hydrofluoric acid burns to the skin usually exhibit a consistent pattern although brief 
contact with a high concentration of HF or exposure to low concentrations of the acid can 
cause the onset of symptoms to be delayed (Vance et. al., 1986).  Exposure to HF 
solutions below 20% can be considerably painful however long-term morbidity is usually 
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not a result (Upfal & Doyle, 1990).  A delay of up to 24 hours before the onset of pain is 
not uncommon with solutions under 50 percent (Edelman, 1986).  The associated pain 
has been described as “deep”, “throbbing”, “burning”, and “excruciating” (Vance et. al., 
1986).  Physical signs of swelling and erythema might be faint at this point. If erythema 
is present, it can be well demarcated and localized or diffuse.  An area of induration has 
been observed in some cases and the skin may appear brown or black in color (Edelman, 
1986).  Blistering is uncommon, especially if the exposure is to the fingertips. Subungual 
exposure typically produces a gray, black, or bluish discoloration of the nail bed, which is 
a very important sign of a serious injury (Edelman, 1986).  Concentrations of 
hydrofluoric acid above 50% are frequently associated with immediate pain.  Exposed 
skin may take on a blanched appearance and feel leathery.   It is common to see skin lines 
obliterated by edema fluid causing the area to be raised (Edelman, 1986).  Eschar 
formation and lequefaction necrosis may also be seen along with tissue sloughing (Upfal 
and Doyle, 1990).   
 
Ocular Exposure 
The lipophilic characteristic of hydrofluoric acid allows it to deeply penetrate the cornea 
of the eye (Beiran et. al., 1997).  The effects of the exposure are usually noted within one 
day although one case of corneal damage was reported to have been delayed until the 
fourth day after exposure (Upfal and Doyle, 1990).  The symptoms of ocular exposure 
include conjunctival inflammation, corneal epithelial coagulation and sloughing, and 
chemosis.  Later effects include the development of chronic conjunctival and corneal 
inflammation and scarring (Upfal and Doyle, 1990). 
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Treatment 
Exposures to hydrofluoric acid need to be treated promptly in order to prevent systemic 
fluoride poisoning (Vance et. al., 1986).  If left untreated, 7 milliliters of 99% HF could 
theoretically bind to all of the calcium in a 154-pound person (Mistry & Wainwright, 
1992).  In the case of 100% hydrofluoric acid, death has been a result of a burn to only 
2.5% of the body surface area (Edelman, 1986).  Historically, hydrofluoric acid burns 
have been treated using tannic acid, zinc oxide, silver nitrate, and steroids, however none 
of these methods are accepted today (Mistry & Wainwright, 1992).  More recent methods 
have included benzalkonium chloride or benzithonium chloride, magnesium oxide, and 
sulfate ointments.  These methods have also been unable to prove themselves effective in 
the binding of free fluoride ions (Mistry & Wainwright, 1992).  Today, the preferred 
method of treatment in the United States for both cutaneous and ocular exposures is 
immediate irrigation with water for 15 to 20 minutes to wash away excess acid and to 
dilute the remaining HF. Calcium gluconate is used following this process to treat the 
exposed area. (Mistry & Wainwright, 1992).  In Europe, particulary in France and 
Germany, a product called Hexafluorine is gaining popularity. 
 
Treatment of Cutaneous Exposures With Calcium Gluconate 
Calcium gluconate manages hydrofluoric acid burns by precipitating the fluoride in the 
form of an insoluble salt (Upfal & Doyle, 1990). Calcium gluconate is often administered 
to an exposed individual in one of, or a combination of, three ways: as a topical gel, as an 
injection, or intra-arterially (Mistry & Wainwright, 1992).  Following a 15 to 20 minute 
water lavage, topical therapy should be initiated. Calcium gluconate gel consists of 2.5% 
calcium gluconate and a lubricant such as KY-jelly.  The gel is easily applied to the 
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affected area and is painless. The disadvantage to this gel is that it may have limited 
effectiveness in treating burns with delayed onset of symptoms, as its penetration might 
not be adequate to bind to fluoride ions deep in the tissues.  Subcutaneous injections are 
often the next mode of action if pain persists for more than 45 minutes following 
exposure (Mistry & Wainwright, 1992).  
Injections are typically 5% to 10% calcium gluconate and are administered with a small-
gauge needle directly into and approximately 0.5 cm peripheral to the burn (Upfal & 
Doyle,1990).  Anesthesia is commonly avoided; as pain is an indicator that more 
aggressive therapy is required (Mistry & Wainwright, 1992). The volume of calcium 
gluconate injections should be no more than 0.5 mL per square centimeter of tissue and 
for fingers, no more than 0.5 mL per digit.  Injecting a larger volume could potentially 
cause local compartment syndrome (Upfal & Doyle, 1990).  This could present 
difficulties as there may not be enough calcium to bind to all of the fluoride ions.  For 
example, 0.5 mL of 10% calcium gluconate contains only 4.2 mg of elemental calcium.  
This amount has been calculated to neutralize only 0.025 mL of 20% hydrofluoric acid.  
Injections can also be painful, particularly in subungual exposures, as injections may 
have to be made directly into the nail bed. This is accomplished by either creating burr 
holes in the fingernails or by completely removing them.  Injections can be repeated as 
needed to bind fluoride ions, treat pain, and limit tissue damage (Upfal & Doyle, 1990).  
An alternative to subcutaneous calcium gluconate injections, especially useful in treating 
digital burns, are 4-hour, intra-arterial infusions through the radial or brachial artery.  
This method provides the best calcium delivery and eliminates the need for fingernail 
removal.  It also reduces the probability of subsequent skin grafting. Risks involved with 
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intra-arterial infusion of calcium gluconate include arterial spasm and local bleeding. 
Therefore, this treatment method is reserved for severe digital burns (Upfal & Doyle, 
1990).  
 
 Case Studies - Calcium Gluconate 
Various case histories and studies have indicated that calcium gluconate is an effective 
treatment for dermal hydrofluoric acid burns. In July of 1980, a man entered the Royal 
Brisbane Hospital complaining of pain in his right hand.  It was learned that he had been 
working with 50% hydrofluoric acid for approximately 12 hours prior to his presentation 
at the hospital.  Two hours after his arrival, rinsing with copious amounts of water and 
application of topical treatments were not successful in alleviating his pain.  At this time 
he was complaining of pain in the palm of his hand and under his nailbeds.  He was in 
distress and suffering erythema and oedema of his hand.  He was treated by inta-arterial 
infusion of 30 mL of 10% calcium gluconate, which resulted in immediate relief of pain.  
After complaining of residual pain in his fingertips, he was injected with 10% calcium 
gluconate subcutaneously and his nails were removed to allow infiltration of the nail bed.  
Twenty-four hours later, he again complained of pain in his fingertips and was given two 
additional injections of calcium gluconate.  He received one more injection on the 
following day.  An X-ray examination of his hand showed no atopic calcification and 
normal bone consistency.  He was discharged from the hospital 4 days later and gained 
full recovery of his hand (Pegg, Siu, & Gillett, 1985). 
Between January 1997 and December 1999, 10 patients were admitted to Kaohsiung 
Medical University Hospital in Taiwan with hydrofluoric acid dermal burns.  The burns 
were to the digits and were caused by variable concentrations of the acid. They were 
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treated using intra-arterial infusions of 10% calcium gluconate with the infusion rate set 
at 10 mL per 12-hour periods.  This was adjusted based on subjective reports of pain.  
The patients’ heart rate, blood pressure, and electrocardiograph were monitored.  Pain 
relief was almost immediate after infusion and none of the patients received pain 
medications.  The average delay between HF dermal burns and treatment was13.5 hours, 
the average infusion time was 39 hours and the total infusion dose 18.3 mL.  The average 
healing time of the digits was 5.8 days. No major complications were noted and all of the 
exposed digits were completely functional and had good cosmetic appearance following 
treatment (Lin, Tsai, Lin & Lai, 2000). 
 
In another study, 48 of 53 patients with hydrofluoric acid burns were successfully treated 
with calcium gluconate gel alone while the remaining 5 patients responded to gel 
followed by calcium gluconate injections.  There were no complications noted (Mistry & 
Wainwright, 1992). 
 
Mistry and Wainwright also describe a case of a laboratory technician who handled 
hydrofluoric acid of an unknown concentration at work and developed intense pain at the 
tip of her finger.  She sought medical attention and was prescribed topical calcium 
gluconate.  Her pain was still severe after 12 hours and she again sought attention at an 
emergency department.  A gray area of skin, 1 cm in diameter, was noted at the tip of her 
right index finger.  There was evidence of extension under the fingernail.  The distal half 
of the nail was removed and the nail bed was irrigated with water.  The patient spent one 
night in the hospital so that 2.5% calcium gluconate gel could be applied every four hours 
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until the pain ceased.  The burn to the finger healed and there were no deformities upon 
re-growth of the fingernail (1992). 
 
In 1987, a 26-year-old male enter a hospital suffering from an exposure to 25% 
hydrofluoric acid.  He was treated with ice-water packs to his fingers and hands.  They 
were also soaked in a saline/calcium gluconate solution.  This treatment was not 
successful in relieving his pain, and visible blistering and discoloration became apparent.  
He was transferred to the intensive care unit where he received 10% calcium gluconate 
through the brachial artery.  This relieved his pain temporarily however; residual pain 
began to occur about 2 hours after the infusion.  At that time, another infusion was 
administered and pain did not recur during the remainder of his hospital stay.  On the 
fourth day following exposure and subsequent treatment, there was a large blister 
containing a thick, yellow exudate, which was surrounded by an area of erythema.  There 
was also a small black area in the nail bed surrounded by an area of coagulation.  By day 
7, there was noticeable improvement, and by day 10, there was complete healing of the 
burned areas including the nail bed.  At this time, the patient was discharged from the 
hospital and suffered no further adverse effects (Edinburg, M. and Swift, R., 1988). 
 
Treatment of Ocular Exposures With Calcium Gluconate 
Upon ocular exposure to hydrofluoric acid, water should be used to irrigate the eyes for a 
minimum of 15 minutes.  The exposed individual should then be brought to medical 
attention for further treatment, including additional water irrigation and the administering 
of 1% calcium gluconate solution (Upfal & Doyle, 1990). 
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Case Studies - Calcium Gluconate 
Beiran, Miller, and Bentur carried out a study on rabbit eyes to determine the efficacy of 
calcium gluconate in ocular hydrofluoric acid burns.  One eye of each rabbit was exposed 
to 0.05 mL of 2% hydrofluoric after they had been anaesthetized.  One minute after the 
introduction of the HF, they underwent treatment with 500 mL normal saline, 1% 
calcium gluconate eyedrops, and additional or substitute methods in some cases.  The 
study indicated that 1% calcium gluconate, administered as drops, might be advantageous 
over alternative therapies but that subconjunctival injections have a possible adverse 
effect (1997). 
 
A clinical report explained by Beiran, Miller, and Bentur documented 1% calcium 
gluconate drops as a treatment for ocular HF burns in humans.  A patient was treated with 
the drops for 5 days and in a follow-up two months later was still suffering from visual 
impairment (1997). 
 
Treatment of Cutaneous Exposures With Hexafluorine 
While rinsing with water only washes away hydrofluoric acid on the surface of skin, the 
product called Hexafluorine, manufactured by Laboratoire PREVOR in France, rinses 
and absorbs HF simultaneously.  Hexafluorine is able absorb the corrosive hydrogen ions 
and bind to fluoride ions using its hypertonicity and chelating properties.  It has greater 
chemical bond energy for HF than do skin tissue receptors therefore rinsing with the 
product immediately following exposure may eliminate the need for further treatment.  
The amount of Hexafluorine used depends on the duration of contact and the extent of 
surface area involved. Hexafluorine showers in 5-liter volumes can be used to 
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decontaminate skin within 2 minutes following exposure (Hall, Blomet, Gross & Nehles, 
1999). 
 
Case Studies - Hexafluorine 
Case histories and studies in Europe have indicated that Hexafluorine is effective in 
hydrofluoric acid burn treatment. During the 4-year period between 1994 and 1998, 11 
workers sustained splashes from hydrofluoric acid.  Six of these burns involved 6% 
HF/15% HNO3 and 5 involved 40% HF.  Exposed areas included the face, eyes, upper 
and lower extremities, hands and thorax. All patients were decontaminated with 
Hexafluorine and no chemical burns or adverse effects were noted in any of the workers. 
None of them had any lost work time (Hall et. al., 1999) 
 
Three cases of workers who were treated with Hexafluorine following hydrofluoric acid 
exposure have been reported to Labortoire PREVOR.  All of the exposures involved 20% 
HF splashes to the skin.  The surface area involved was less than 5% of total body surface 
area in all instances.  The workers were decontaminated with Hexafluorine and no burns 
developed (Josset, Blomet, Lym, Jahan & Meyer, 1992). 
 
Hall et. al. discuss another case report in which a worker fell into a bath containing 1,505 
liters of water, 30 liters of hydrochloric acid and 233 liters of 59% HF.  His entire body 
and head were immersed in the solution.  He was decontaminated with Hexafluorine and 
also used water to rinse his eyes.  He developed minor burns on his back and stomach.  
Although there was a corneal burn to the left eye, the right eye sustained no damage 
(1999). 
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 Between 1998-1999, there were 16 ocular and cutaneous incidents involving HF.  Two of 
the splashes involved 70% HF and the others a mixture of hydrofluoric acid and nitric 
acid at a pH of 1.  The splashes were all rinsed with Hexafluorine and rinsing began 
within 1 minute of exposure for 75% of the cases.  Three splashes were rinsed after an 
hour of contact.  All of the exposed individuals had immediate pain relief during or 
following the rinsing.  60% of the workers were sent to the hospital for follow-up medical 
examinations but none suffered any damage. One of the ocular splashes suffered residual 
pain and one had some blisters on the outside of the eyelid the day after treatment. There 
were no sequelae in the majority of the cases and no secondary care was needed for any 
of the individuals.  The average number of days away from work was 0.9 days (Barbe, J., 
Blomet, J. and Mathieu, L., 2000). 
 
Treatment of Ocular Exposures With Hexafluorine 
As demonstrated in the previous case studies, Hexaflourine can be used for the eyes in 
the same manner it is used for dermal exposures. For ocular exposures, applying 500 mL 
of the product within 2 minutes following exposure has proven to be effective (Hall et. 
al., 1999). 
 
Case Studies - Hexafluorine 
Various case studies have supported the efficacy of Hexafluorine in ocular hydrofluoric 
acid burn treatment.  In July of 1995, a worker sustained a splash of 38% HF to the eye 
from a defective pipe.  He rinsed his eye with Hexafluorine, sustained no injury, and 
returned to work the following day (Siewe, Nehles, Blomet & Gross, 1998). 
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 A worker in 1995 sustained an ocular and dermal exposure involving 40% hydrofluoric 
acid.  His clothes were saturated with HF. The clothes were torn from his body and 
coworkers rinsed him with Hexafluorine.  His eyes were rinsed one more time with the 
product and he was taken to the hospital where he was examined.  No damage was found 
and he returned to work the following day (Siewe et. al., 1998).  
 
Comparison of Calcium Gluconate and Hexafluorine 
An in vitro study was carried out to simulate decontamination effects without flushing.  
Ten milliliters of 0.1 Normal hydrofluoric acid (0.2%) was placed into a beaker, and 
water along with either 10% calcium gluconate or Hexafluorine were added.  The pH and 
pF were subsequently measured.  It was concluded that water had very little effect on 
either variable.  It was also discovered that Hexafluorine bound the hydrogen ion 100 
times greater than calcium gluconate.  The final pH value with Hexafluorine was 6.5 
while it was 4.5 with calcium gluconate.  The causticity limit of the hydrogen ion is a pH 
value of 5.5 indicating that despite the use of calcium gluconate, a caustic injury still may 
occur.  The final pF value with calcium gluconate was 3.0 versus 6.0 for Hexafluorine.  
The toxicity limit is a pF value less than 5.0.  The results then indicate that although 
fluoride tissue toxicity should not occur following the use of Hexafluorine, it may occur 
despite the use of calcium gluconate (Hall et. al. 1999).  
 
In a recent animal study, 120 New Zealand albino rabbits were separated into 6 groups 
and exposed to 70% hydrofluoric acid.  The exposure was carried out by applying a piece 
of filter paper, saturated in HF, to a surface area of less than 1% of the body.  After the 
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exposure, the areas were flushed with water for 5 minutes followed by an application of 
2.5% calcium gluconate gel, or decontamination with Hexafluorine for 3 minutes at a rate 
of 0.2 liters per minute.  Observations were made at 10 minutes, 1 hour, 2 hours, and 
every 24 hours for 6 days.  At 10 minutes, 1 hour, and 2 hours, no burns were visible on 
the rabbits treated with calcium gluconate.  However, burns were visible on the first and 
second days and were severe on the third through sixth days.  The rabbits irrigated with 
Hexafluorine showed no burns at any time during the study (Hall et. al. 1999). 
 
Another animal study was conducted using 62 adult male Charles River Wistar rats.  
They were divided into groups of 20 animals and the remaining 2 were used as 
unexposed controls.  All of the rats and burns induced by application of a 1 centimeter 
square piece of filter paper saturated with 70% hydrofluoric acid to the skin.  The three 
groups were then treated using 3 different methods: water irrigation alone, water 
irrigation plus calcium gluconate inunction, and rinsing with Hexafluorine.  Serum 
calcium levels were measured to determine if hypocalcemia occurred and if there were 
differences in patterns over time in the animals undergoing the different methods of 
treatment.  With the water irrigation alone and water irrigation plus calcium gluconate 
inunction, hypocalcemia was present from 10 minutes to 4 hours following exposure.  
Over a five-day period, the serum calcium levels returned to normal.  With Hexafluorine 
irrigation, the pronounced calcium deficiency was not seen at the four-hour mark as it 
was in the first two animal groups.  At the five-day mark, levels were similar to control 
values (Blomet, J., Gross, M., Hall, A., Nehles, J., 1999). 
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Summary 
This literature review presented information regarding the hazards associated with 
hydrofluoric acid use and described the effectiveness of the treatment methodologies in 
question.  Comparisons were made between calcium gluconate and Hexafluorine with 
respect to application, mode of action, and effectiveness. This data is essential in 
providing a basis for even further comparison of these two products in Chapter 4. 
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Chapter III 
Methodology 
 
This chapter will outline the methods used for research in this study.  Information was 
gained through a review of professional literature and was also obtained via vendors and 
manufacturers.  The process that follows was used in gathering data relevant to the 
purpose and objectives of this study: 
 
 
1.0 A literature search and review of hydrofluoric acid use in the semiconductor industry 
and the hazards associated with its use. 
 
2.0 Research of professional literature to determine: 
• Use and effectiveness of calcium gluconate as treatment following HF exposure 
through analysis of case studies 
• Benefits and/or adverse effects of calcium gluconate 
 
3.0 Research of professional literature to determine: 
• Use and effectiveness of Hexafluorine as treatment following HF exposure 
through analysis of case studies 
• Benefits and/or adverse effects of Hexafluorine  
 
4.0 Obtain information from vendors and manufacturers via phone, company literature, 
and case studies to assist in establishing which is the preeminent treatment. 
 
5.0 Use information gained from literature review to compare and contrast the above 
treatments in the areas of effectiveness, benefits and/or adverse effects, and cost. 
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Chapter IV 
The Study 
 
The purpose of this study is to compare and contrast calcium gluconate and Hexafluorine 
as treatments for hydrofluoric acid exposure.  Information on the characteristics, 
effectiveness, availability, and cost of each option is formatted to provide a clear 
understanding of the differences between the treatment methodologies. 
 
Efficacy of Calcium Gluconate 
Data has shown that calcium gluconate is an effective treatment for hydrofluoric acid 
exposure.  In most cases, individuals who sustain an exposure to HF have full recovery of 
the affected areas following treatment.  However, calcium gluconate has a limited ability 
to neutralize hydrogen ions and thus allows for initial and secondary caustic burns of the 
exposed area. Calcium gluconate gel is very easy to use, but has limited efficacy, as it 
cannot bind to fluoride ions that have penetrated deep into the body tissues.  It is also 
common for the gel to have to be repeatedly applied for a period of days or sometimes 
weeks, and it is often necessary to follow its application with injections or intra-arterial 
infusions.  Injections of calcium gluconate are effective but can be painful considering 
fingernails may need to be removed, and the calcium gluconate itself can burn upon 
entering the body.  Intra-arterial infusions of calcium gluconate have proven to be 
effective as well, however the treatment is invasive and sometimes results in adverse 
effects such as arterial spasm and local bleeding. In addition, calcium gluconate has 
limited effectiveness as a treatment for ocular exposure and can actually produce a toxic 
effect if injected into the eye. 
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Availability of Calcium Gluconate 
Since its approval by the Food and Drug Administration, calcium gluconate has become 
the standard treatment for hydrofluoric acid burns in the United States.  Calcium 
gluconate can be purchased through a variety of vendors however; Pharmascience Inc. in 
Quebec, Canada is the main supplier (Segal, E., 2000).  A semiconductor company also 
has the option of mixing their own solutions.  Topical gel (2.5% calcium gluconate) can 
be produced by mixing one 10-mL ampule (10%) per 1 ounce of K-Y Lubricating Jelly, 
and eye wash solutions can be made by mixing one 10-mL ampule (10%) per 90 mL of 
saline to get a 1% calcium gluconate solution.  The shelf life for these mixtures has not 
been determined and it is recommended that they be replaced after a 6-month period. 
 
Cost of Calcium Gluconate  
Semiconductor companies can save on cost if they choose to mix their own calcium 
gluconate solutions, however many companies opt to buy from a vendor.  Calcium 
gluconate gel is available through Pharmascience Inc. at a cost of $264.60 for 12, 25-g 
tubes plus an additional charge of 5% for shipping and handling.  Quantities of 6 are 
available for $165.30. The 10% calcium gluconate solution used for injections and intra-
arterial infusions can be found at some hospital pharmacies for a cost of $5.89 per 10-
mL.  The cost of calcium gluconate appears to be low however in the unlikely event that 
an exposure to hydrofluoric acid should occur, this cost could become much higher.  In 
some cases, calcium gluconate gel has proven to be sufficient to stop damages from HF, 
however in many cases, additional treatment at a medical facility is necessary.  As noted 
in Chapter II case studies, hospital visits can last anywhere from hours to days.  An 
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overnight stay in one hospital was reported to be $868 per night not including anything 
additional, such as cost of medications and treatment.  In addition to this cost is the 
employee’s paid time away from work.  According to Francisco Moris (2000), the 
average wage for a semiconductor production worker in 1995 was $14.59 per hour.  It 
should be mentioned that as an employer, you are expected to pay 100% medical and 
disability benefits which vary in accordance with the injury.  When a semiconductor 
company adds up the costs, they may find that treatment of a severe HF exposure with 
calcium gluconate could end up costing upwards of $1,000 per day for the duration of the 
treatment. 
 
Efficacy of Hexafluorine 
The information collected through various studies indicates that Hexafluorine is also an 
effective treatment for hydrofluoric acid exposures.  Hexafluorine is used as an aqueous 
wash and is equally effective for both the skin and eyes. This product has the ability to 
bind both the hydrogen and fluoride ions preventing both caustic burns and systemic 
fluoride poisoning. The manufacturer recommends that Hexafluorine be utilized 
immediately, within 2 minutes, after exposure.  Hexafluorine replaces the need for initial 
rinsing with water, which is why this window of time is so small.  If used within this time 
frame, this product has shown that it has the ability to prevent all adverse effects.  If 
Hexafluorine were to be utilized, say after 1 hour, it would be effective in treating any 
further damage but would not correct the damages that have already occurred.  There has 
not been an observed secondary burn as of today following decontamination with this 
product and additional treatment is rarely necessary.   
 24
Availability of Hexafluorine 
Hexafluorine is available in all of Europe and is being extensively used in France and 
Germany.  It is also available in Taiwan and China, however it is not yet available in 
Japan due to customs issues.  Hexafluorine is available in the United States as a 5L 
volume portable shower, which is to be used as a decontaminant for skin exposures but 
not as an eyewash solution. The FDA has not yet approved the use of Hexafluorine as 
first aid for the eyes, as this type of use would be considered medical rather than cosmetic 
in nature.  Laboratoire PREVOR, the manufacturer of Hexafluorine, has a vendor in the 
United States called Safe Stride, which is located in Washington State. It should also be 
noted that Hexafluorine has a shelf life of 2 years. 
 
Cost of Hexafluorine 
There are very few semiconductor companies utilizing Hexafluorine in the United States, 
although there are several semiconductor equipment manufacturers that do use the 
product.  This could be in part due to lack of knowledge or possibly because it is only 
available in the 5L volume shower.  Most semiconductor companies deal with 
hydrofluoric acid exposures small enough that this large quantity would not be required.  
The cost of Hexafluorine is $1,620 per 5 liters, which initially is much higher than the 
cost of calcium gluconate solutions.  However, decontamination of a hydrofluoric acid 
exposure with Hexafluorine can eliminate the need for additional medical treatment 
keeping additional costs at a minimum. Although exposed individuals are often sent for a 
medical evaluation following a rinsing with Hexafluorine, they often sustain no damages 
and do not require a hospital stay or an extended period of time away from work.  
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Therefore, the cost of Hexafluorine should be viewed as the cost of conformance versus 
that of non-conformance, as the cost of non-conformance is a sunk cost; there is no return 
on your investment.  
 
Table II 
Comparison of Calcium Gluconate and Hexafluorine  
 
 Calcium Gluconate Hexafluorine 
Application Gel, Injection, Intra-arterial Infusion 
following water lavage. 
Used in aqueous form as a 
rinsing solution. 
Mode of 
Action 
Binds to fluoride ion forming 
insoluble fluoride salt. 
Binds to both the hydrogen and 
fluoride ions. 
Efficacy Limited ability to bind to hydrogen 
ion. 
Usually results in full recovery 
following cutaneous exposure. 
Limited efficacy when used to treat 
ocular exposures. 
Equally effective for cutaneous 
and ocular exposures. 
No secondary burns have been 
reported following its use. 
Availability Widely available in the United States. 
Main supplier located in Quebec 
Canada. 
Available in the United States 
through a vendor in the state of 
Washington. 
Cost Varies; Company can manufacture 
their own to reduce initial cost. 
Costs associated with secondary 
medical treatment can be substantial. 
 5-Liter shower- $1,620. 
Costs associated with 
secondary medical treatment 
commonly eliminated. 
FDA 
Approval 
Yes Approved as a decontaminant 
for the skin 
Not approved as an eyewash 
solution. 
Shelf-Life 6 months 1.5 Years 
 
 
 
Summary 
Chapter IV supplied information as to the effectiveness, availability, and cost of both 
calcium gluconate and Hexafluorine.  The comparisons drawn in this chapter are the basis 
from which conclusions can be made regarding both treatment methodologies.  
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Chapter V 
Conclusions and Recommendations 
 
 
Introduction 
The purpose of this study was to compare and contrast calcium gluconate and 
Hexafluorine as treatments for hydrofluoric acid exposure.  Chapters two and four 
examined the efficacy, availability, and cost of each treatment methodology.  To fulfill 
the purpose of the study, objectives were set and achieved. 
 
Specific objectives of the study were: 
 
3.0 Examine processes in the semiconductor industry that utilize hydrofluoric acid. 
3.1 Analyze the properties and toxicity of hydrofluoric acid. 
4.0 Analyze and evaluate calcium gluconate and Hexafluorine to establish which is the 
preeminent treatment methodology. 
 
Conclusion 
The conclusions of this study are based on information gathered from vendors, 
manufacturers, and the literature review.  They are drawn from comparisons made in 
Chapter IV and are organized according to the corresponding goals.  The first objective 
of the study was to examine processes in the semiconductor industry that utilize 
hydrofluoric acid.  This included doing an analysis of the properties and toxicity of HF.  
Semiconductor companies utilize hydrofluoric acid in several processes including silicon 
dioxide wet etching, reaction chamber cleaning, and the removal of oxides from silicon 
 27
surfaces.  This wide use of HF has facilitated it becoming the most common burn-
producing chemical in the industry.  Hydrofluoric acid possesses unique properties that 
make it very toxic to humans.  HF has a low dissociation constant thus making it highly 
lipophilic.  Once absorbed into the body, the hydrogen and fluoride ions separate.  The 
hydrogen ion is then free to cause a secondary burn, which includes symptoms such as 
eschar formation, liquefaction necrosis and sloughing.  The fluoride ion seeks out 
calcium in the body, which can lead to hypocalcemia and death.  The severity of the 
symptoms associated with hydrofluoric acid exposure indicate that immediate treatment 
is imperative.  
 
The second objective was to analyze and evaluate calcium gluconate and Hexafluorine to 
establish which is the preeminent treatment.  Both treatment methodologies researched 
have proven to be effective treatments following exposure to this chemical. Calcium 
gluconate has the ability to bind to the fluoride ion thus preventing systemic poisoning 
however; it has limited efficacy in binding the hydrogen ion and therefore allows for 
secondary caustic burns.  In addition, there is debate as to whether it is effective as a 
treatment for ocular exposures.  It has become the standard treatment for hydrofluoric 
acid burns in the United States since its approval by the Food and Drug Administration. 
Semiconductor companies have the option of producing their own calcium gluconate gel 
and solutions, or purchasing it from a vendor.  The initial cost of calcium gluconate is 
low however; case studies show that hydrofluoric acid exposures treated with this product 
commonly require secondary treatment at a medical facility increasing cost 
tremendously.    
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 Hexafluorine has the ability to bind both the hydrogen and fluoride ions preventing both 
caustic burns and systemic fluoride poisoning. There has not been an observed secondary 
burn as of today following decontamination with this product and secondary treatments 
are rarely necessary.   The FDA has approved Hexafluorine in the United States as a skin 
decontaminant but it has not been approved as an eyewash solution.  Therefore, 
semiconductor companies in the U.S. can purchase Hexafluorine in the 5-Liter volume 
but not in the smaller volume that would be used for rinsing the eyes.  Although the 
initial cost of Hexafluorine is much higher than calcium gluconate, the costs associated 
with secondary treatment, which can be substantial, are commonly eliminated following 
treatment with this product. 
 
Although availability and cost of each product are aspects that semiconductor companies 
may consider; when dealing with an exposure of such severity it is important that the 
most efficacious treatment be used.  The information gathered in this study shows that 
Hexafluorine is the most efficacious treatment for hydrofluoric acid exposures. 
 
Recommendations 
When dealing with a chemical as hazardous as hydrofluoric acid, it is important that 
semiconductor companies have stringent engineering and administrative controls in place 
to control the associated risks.  Although prevention is the best treatment, in the event of 
an exposure to HF immediate treatment with the most efficacious treatment available is 
imperative.   
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Hexafluorine has proven to be the preeminent HF treatment methodology available at the 
present time.  Although it has been approved in the U.S. as a decontaminant for the skin, 
it is recommended that the Food and Drug Administration further examine all 
information available on this product and consider approving Hexafluorine as a 
decontaminant for the eyes as well. 
It is also recommended that all semiconductor companies that utilize hydrofluoric acid 
have Hexafluorine available for immediate decontamination of cutaneous exposures at 
their facilities.  Calcium gluconate solution (1%) should be available for exposures 
sustained to the eyes, as Hexafluorine has not yet been approved as a treatment for ocular 
exposures.  Cutaneous exposures associated with small volumes and low concentrations 
of hydrofluoric acid may also be successfully treated using calcium gluconate.  Calcium 
gluconate gel might also be applied following decontamination with Hexafluorine to 
ensure optimal results.  
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